97 related articles for article (PubMed ID: 4731230)
21. Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
Neil GL; Buskirk HH; Moxley TE; Manak RC; Kuentzel SL; Bhuyan BK
Biochem Pharmacol; 1971 Dec; 20(12):3295-308. PubMed ID: 5002403
[No Abstract] [Full Text] [Related]
22. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
[TBL] [Abstract][Full Text] [Related]
23. In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.
Dedrick RL; Forrester DD; Ho DH
Biochem Pharmacol; 1972 Jan; 21(1):1-16. PubMed ID: 4500983
[No Abstract] [Full Text] [Related]
24. Alkylated cytosine nucleosides: substrate and inhibitor properties in enzymatic deamination.
Krajewska E; Shugar D
Acta Biochim Pol; 1975; 22(2):185-94. PubMed ID: 1098340
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy of acute leukemia with cyclocytidine, with special reference to serum ara-C deaminase activity (author's transl)].
Nakamura T; Sasada M; Sawada H; Higuchi T; Tatsumi K
Nihon Ketsueki Gakkai Zasshi; 1977 Jun; 40(3):293-9. PubMed ID: 72473
[No Abstract] [Full Text] [Related]
26. [Isolation of intracellular cytidine deaminase from Penicillium sizowi and study of its properties].
Bezborodov AM; Reshetilova TA; Golubenko IA
Mikrobiologiia; 1974; 43(4):600-5. PubMed ID: 4453206
[No Abstract] [Full Text] [Related]
27. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
[TBL] [Abstract][Full Text] [Related]
28. Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
Liss RH; Neil GL
Cancer Chemother Rep; 1975; 59(3):501-13. PubMed ID: 1203880
[TBL] [Abstract][Full Text] [Related]
29. A kinetic study of the deamination of some adenosine analogues. Substrate specificity of adenosine deaminase.
York JL; LePage GA
Can J Biochem; 1966 Mar; 44(3):331-7. PubMed ID: 5934241
[No Abstract] [Full Text] [Related]
30. Ara-C metabolism: implications for drug resistance and drug interactions.
Chabner BA; Hande KR; Drake JC
Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952
[TBL] [Abstract][Full Text] [Related]
31. Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.
Wang MC; Sharma RA; Bloch A
Cancer Res; 1973 Jun; 33(6):1265-71. PubMed ID: 4578070
[No Abstract] [Full Text] [Related]
32. Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine.
Zhang M; Endo Y; Sasaki T
Int J Oncol; 1999 Mar; 14(3):543-9. PubMed ID: 10024689
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
Lemaire M; Momparler LF; Raynal NJ; Bernstein ML; Momparler RL
Cancer Chemother Pharmacol; 2009 Feb; 63(3):411-6. PubMed ID: 18398609
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy of the malignancies from the viewpoint of pharmacology and biochemistry of cytosine arabinoside (ara-C) and its derivatives].
Nakamura T; Ueda T
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1339-51. PubMed ID: 6191711
[TBL] [Abstract][Full Text] [Related]
35. Deamination rates of 1-beta-D-arabinofuranosylcytosine, deoxycytidine and 5-methyl-2'-deoxycytidine in seven hematopoietic cell lines.
Jekunen A
Med Biol; 1987; 65(4):203-8. PubMed ID: 3437781
[TBL] [Abstract][Full Text] [Related]
36. Antitumor characteristics of the conjugate of N4-(4-carboxybutyryl)-ara-C with ethylenediamine-introduced dextran and its resistance to cytidine deaminase.
Onishi H; Pithayanukul P; Nagai T
Drug Des Deliv; 1990 Oct; 6(4):273-80. PubMed ID: 1707277
[TBL] [Abstract][Full Text] [Related]
37. Nucleic acids. X. Enzymatic hydrolysis of dinucleoside phosphates containing ara-cytidine (cytarabine).
Zeleznick LD
Biochem Pharmacol; 1969 Apr; 18(4):855-62. PubMed ID: 5788523
[No Abstract] [Full Text] [Related]
38. Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC.
Takenaka T; Kimura K
Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):938-49. PubMed ID: 6209907
[No Abstract] [Full Text] [Related]
39. Effects of psychotropic drugs on deaminase in CNS.
Farská I; Krulík R
Act Nerv Super (Praha); 1978 Feb; 20(1):58-9. PubMed ID: 636777
[No Abstract] [Full Text] [Related]
40. Antitumor activity of cyclocytidine derivatives.
Hoshi A; Kanazawa F; Kuretani K; Kanai T; Kikugawa K
Gan; 1973 Oct; 64(5):519-22. PubMed ID: 4769741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
